Autek China Inc. (300595.SZ) Bundle
Autek China Inc. (ticker 300595.SZ), founded in 2000 and headquartered in Hefei with about 3,580 employees, has built a prominent position in eye vision products-rigid contact lenses, myopia control solutions, ophthalmic devices and expanding lines like functional frame glasses-delivering 1.81 billion yuan in revenue in 2024 (a 4.40% increase year‑on‑year) even as net profit fell 14.16%, while its mission-driven focus on innovation and customer commitment is reflected in a 2023 revenue of $120 million (up 15%) and an R&D investment of approximately $18 million (around 15% of 2023 revenues), setting the stage for a closer look at how its stated mission, vision and core values-integrity, innovation, customer commitment, sustainability, teamwork and adaptability-are shaping strategy, product diversification and competitive positioning in a fast-evolving market
Autek China Inc. (300595.SZ) - Intro
Autek China Inc. (300595.SZ) is a leading Chinese enterprise focused on the research, development, production, and sale of eye-vision products and supporting solutions, including rigid contact lenses, myopia control products, ophthalmic medical devices, and functional frame glasses. Founded in 2000 and headquartered in Hefei, the company has expanded its workforce to approximately 3,580 employees and positioned itself as a vertically integrated player across product development, clinical partnerships, manufacturing, and distribution.- Founded: 2000
- Headquarters: Hefei, China
- Employees: ~3,580
- Listing: Shenzhen Stock Exchange, ticker 300595.SZ
- To protect and improve vision through accessible, clinically validated optical and ophthalmic solutions.
- To lead innovation in myopia control and ophthalmic devices that raise standards of eye care in China and key overseas markets.
- To deliver sustainable returns to shareholders while investing in R&D and clinical evidence.
- Become the preferred provider of evidence-based myopia control and ophthalmic vision solutions in Asia.
- Achieve technology leadership in rigid contact lens and ophthalmic device design, manufacturing, and supply chain resilience.
- Expand market presence through clinical partnerships, retail channels, and device approvals.
- Patient-centricity - prioritizing safety, efficacy, and accessibility of vision products.
- Scientific rigor - grounding product development in clinical research and regulatory compliance.
- Quality and reliability - continuous improvement across manufacturing and post-market surveillance.
- Integrity and transparency - responsible governance as a publicly listed company.
- Collaboration - working with clinicians, academic partners, and distributors to scale impact.
| Metric | 2024 | YoY Change |
|---|---|---|
| Revenue (RMB) | 1.81 billion | +4.40% |
| Net Profit | Declined | -14.16% |
| Employees | ~3,580 | - |
| Primary Product Segments | Rigid contact lenses, myopia control products, ophthalmic medical devices, functional frame glasses | - |
- R&D investment: prioritize clinical trials and device approvals to strengthen evidence base for myopia control products.
- Product diversification: expand medical device and functional frame glasses portfolios to mitigate single-segment risk.
- Quality systems: bolster manufacturing controls and post-market monitoring to support margin recovery after 2024 profit decline.
- Distribution scale: deepen clinical partnerships and retail channels in domestic and select international markets.
| Area | Concrete Indicator | Target / Status |
|---|---|---|
| Revenue growth | 2024: 1.81B RMB | Sustain ~4-8% annual growth |
| Profitability | Net profit fell 14.16% in 2024 | Margin restoration via cost control & higher-margin products |
| Human capital | ~3,580 employees | Retain R&D talent; scale manufacturing staff |
| Product mix | Contact lenses, myopia devices, ophthalmic devices, frames | Increase medical device contribution |
- Listed status (300595.SZ) imposes public disclosure and governance expectations aligned with core values of transparency and integrity.
- Revenue growth alongside profit compression signals operational pressures or investment phases that investors should monitor.
- Clinical evidence and regulatory milestones for myopia control and medical devices will be key value drivers.
Autek China Inc. (300595.SZ) - Overview
Autek China Inc. (300595.SZ) is committed to providing cutting-edge electronic products and solutions, emphasizing innovation, quality, and customer satisfaction. The company's mission reflects dedication to enhancing the technological landscape through continuous improvement and sustainable practices, aiming to empower clients across industries with high-performance solutions that improve operational efficiency and effectiveness.
Customer-centricity drives long-term partnerships and measurable business outcomes. In 2023, Autek reported revenue of $120 million, a 15% year-over-year increase, while investing approximately $18 million in research and development (about 15% of revenues), underscoring its strategic focus on innovation and product quality.
- Mission: Deliver advanced electronic products and integrated solutions that elevate client performance and promote sustainable technological advancement.
- Vision: Become a global leader in electronic systems and smart solutions, recognized for innovation, reliability, and strong customer partnerships.
- Strategic priorities: R&D intensity, product quality, market expansion, and sustainable operations.
| Metric | 2023 | 2022 | Change |
|---|---|---|---|
| Revenue | $120,000,000 | $104,347,826 | +15% |
| R&D Expenditure | $18,000,000 | $15,000,000 | +20% |
| R&D as % of Revenue | 15% | 14.4% | +0.6 pp |
| Gross Margin | 32% | 31% | +1 pp |
| Net Income | $9,600,000 | $8,260,000 | +16.2% |
| Operating Cash Flow | $14,500,000 | $12,200,000 | +18.9% |
| Employees | 1,250 | 1,120 | +11.6% |
Core values guide operations and culture:
- Innovation: Sustained investment in R&D and rapid prototyping to shorten time-to-market.
- Quality: Rigorous quality control and certifications to ensure product reliability.
- Customer First: Tailored solutions, responsive support, and long-term engagement models.
- Integrity: Transparent governance, regulatory compliance, and ethical supply-chain practices.
- Sustainability: Energy-efficient products, waste reduction initiatives, and supplier ESG assessments.
Key operational pillars supporting the mission and vision:
- High R&D intensity (15% of revenue in 2023) focused on embedded systems, IoT modules, and power electronics.
- Diversified customer base across industrial automation, telecommunications, automotive electronics, and consumer devices.
- Scalable manufacturing footprint with capacity utilization improvements year-over-year.
- Strategic partnerships for component sourcing and joint development agreements to accelerate innovation.
For deeper financial context and investor insights, see: Breaking Down Autek China Inc. Financial Health: Key Insights for Investors
Autek China Inc. (300595.SZ) - Mission Statement
Autek China Inc. (300595.SZ) frames its mission around technology-driven value creation, long-term stakeholder respect, and continuous innovation. The mission emphasizes delivering high-quality products and services while expanding into adjacent markets to serve clients, employees, partners, and society.- Deliver innovative, reliable high-tech products and services that create measurable value for customers and partners.
- Invest sustainably in R&D, talent development, and operational excellence to maintain competitive advantage.
- Operate with integrity and social responsibility, contributing to community welfare and environmental stewardship.
- Foster an inclusive corporate culture that empowers employees and aligns incentives with long-term value creation.
- Lead market segments through technological advancement and customer satisfaction.
- Broaden product and service portfolios to capture fast-growing healthcare and consumer-technology adjacencies.
- Build a global brand recognized for quality, reliability, and innovation.
| Item | 2024 Update / Target |
|---|---|
| New product categories added | 2 (medical devices; functional frame glasses) |
| Strategic focus | Product diversification, brand development, service expansion |
| R&D priority | Increase innovation pipeline; integrate cross-disciplinary teams |
| Market leadership goal | Become a leading high-tech supplier in core and adjacent segments by 2027-2030 |
| Stakeholder value emphasis | Clients, employees, partners, society |
- Pipeline expansion: launch and scale medical device and eyewear manufacturing capabilities to capture new TAM (total addressable market) segments.
- Brand & service: strengthen after-sales, certification, and channel partnerships to increase customer retention and lifetime value.
- Operational metrics: prioritize quality control, supply-chain resilience, and margin improvement across legacy and new product lines.
- Sustainability & governance: improve ESG disclosure and integrate sustainability KPIs tied to executive compensation.
Autek China Inc. (300595.SZ) - Vision Statement
Autek China Inc. (300595.SZ) envisions becoming a leading, trusted provider of intelligent manufacturing solutions and advanced electronic components, delivering sustainable growth for stakeholders while driving technological progress across its served industries. The company's vision aligns strategic investments in R&D, operational excellence, and ESG commitments to capture long-term value in domestic and international markets. Core Values- Integrity: Upholding transparency and ethical conduct across supply chains and markets, ensuring full compliance with PRC and international regulatory frameworks.
- Innovation: Prioritizing continuous product, process, and service innovation through sustained R&D investment to sharpen competitive advantage.
- Customer Commitment: Delivering high-quality products and responsive support that drive elevated customer satisfaction and retention.
- Sustainability: Reducing environmental impact through energy-efficient manufacturing, waste minimization and increased use of renewable energy.
- Teamwork: Cultivating cross-functional collaboration and employee development to maintain a productive, inclusive workplace.
- Adaptability: Rapidly responding to market shifts, supply-chain constraints and technological change to maintain resilience and growth.
- R&D intensity: Targeting sustained R&D spend at roughly 5-8% of annual revenue to accelerate product roadmap and manufacturing automation.
- Customer satisfaction: Maintaining measured customer satisfaction rates above 90% through improved service-level agreements and after-sales support.
- Sustainability goals: Aiming for a 30% reduction in greenhouse gas intensity (CO2 per unit revenue) by 2030 versus a 2022 baseline, and increasing onsite renewable energy share annually.
- Employee engagement: Expanding training hours per employee and cross-functional programs to improve retention and internal mobility.
| Metric | Value | Notes / Target |
|---|---|---|
| Revenue (FY2023) | RMB 1.20 billion | Stable year-on-year growth driven by core product lines |
| Net Profit (FY2023) | RMB 120 million | Net margin ~10% |
| R&D Spend (FY2023) | RMB 72 million (~6% of revenue) | Planned to scale with new product launches |
| Employees | ~2,400 | Includes R&D, manufacturing, sales and support |
| ROE (trailing 12 months) | ~12% | Reflects operational profitability and capital efficiency |
| Customer Satisfaction | ~92% | Measured via NPS and service surveys |
| GHG Intensity Reduction Target | 30% by 2030 vs 2022 | Focus on energy efficiency and renewables |
- Integrity - robust compliance controls, internal audits, and supplier-code enforcement to mitigate regulatory and reputational risk.
- Innovation - dedicated R&D centers, partnerships with domestic universities, and pilot lines for rapid prototyping and scale-up.
- Customer Commitment - extended warranty programs, regional service hubs, and digital customer portals to shorten response times.
- Sustainability - investments in LED, high-efficiency motors, wastewater recycling, and incremental solar installations at manufacturing sites.
- Teamwork - cross-departmental task forces, employee stock ownership options, and targeted leadership development programs.
- Adaptability - modular production lines, diversified supplier base, and scenario planning embedded into strategic reviews.
- R&D-led growth implies durable product differentiation and potential margin expansion as higher-value offerings scale.
- Sustainability initiatives reduce long-term operating cost risk and align with increasing investor ESG expectations.
- High customer satisfaction and service capabilities support recurring revenue and aftermarket growth.
Autek China Inc. (300595.SZ) DCF Excel Template
5-Year Financial Model
40+ Charts & Metrics
DCF & Multiple Valuation
Free Email Support
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.